Saved To My Saved Content
Download Article
Use BCG Answer to summarize this article

Capital management is at the heart of value creation for insurance companies. It drives the capital productivity and cash generation that underpins dividends, growth, and strategic flexibility. Recognizing this, many insurers have worked hard in recent years to improve their capital-management practice by defining clear capital KPIs, embedding them in decision making, and building governance around them. Yet the maturity of this practice still varies widely. Some insurers steer capital with sophistication, while many others, though more advanced than a decade ago, still have considerable ground to cover.

For those at the less sophisticated end of the spectrum, the conversations with investors and analysts are becoming increasingly difficult. How insurers steer capital is being scrutinized more closely and systematically than ever. But even those with advanced capital-management capabilities are facing more probing questions from investors and analysts who want to know exactly how they are turning capital strength into value, thus raising the bar for capital management excellence. This article examines the capabilities that differentiate the leaders and how other insurers can close the gap and turn capital management into a durable source of value.

Sound Capital Management Builds Confidence

Some insurers, particularly those in the UK and the Netherlands, have been steering and reporting on capital generation and cash remittance for years. Others have reported on capital management largely in terms of solvency requirements and considered cash, returns, and growth as separate and distinct performance criteria. But today, with solvency ratios uniformly strong and capital generation robust across major European insurers, the questions from investors and analysts have become more pointed.

For example: How stable and sustainable is reported capital generation, or is it flattered by one-off effects and favorable markets? How does capital generation convert into cash at the holding company? How will the company deploy excess capital across dividends, buybacks, organic growth, and M&A, and why is that allocation the best choice? As one analyst put it, “Solvency is not the issue for any of these names. The question is what the capital is actually worth.”

These questions were not entirely absent in the past, but they are now asked more consistently and precisely. And the capital test is harder than it was in the past. When an insurer can clearly demonstrate how its capital converts into cash, returns, and growth, it builds confidence; when an insurer cannot, questions mount and valuations can suffer—even when the headline solvency ratio and capital generation look strong. One analyst told us, “What matters now isn’t the surplus, it’s what they can actually do with it.”

Two developments may raise the bar even higher for capital management excellence. The Solvency II Review, which will take effect in early 2027, is likely to lift solvency coverage ratios for many European insurers, creating a timely opportunity for CFOs to reassess capital allocation and revisit decisions. But additional headroom does not automatically translate into capital that can be put to work. Local statutory and accounting constraints, fungibility, and management buffers will determine how much ultimately becomes available for redeployment. The impact will differ across insurers, depending on business mix, asset allocation, and balance sheet characteristics.

At the same time, higher interest rates, while supporting coverage ratios, have left unrealized losses on many local balance sheets. This could constrain the conversion of reported capital strength into distributable cash. The distinction is critical: one euro of additional regulatory headroom is not necessarily one euro available for redeployment. The management challenge is to determine how much capital can actually be converted into deployable resources and where those resources create the most value. For insurers that get this right, the coming years offer a window to pull ahead.

What Best in Class Looks Like

An insurer’s progression toward capital management excellence begins with a focus on regulatory compliance and advances to managing capital, integrating KPIs, and, ultimately, optimizing value. (See Exhibit 1.) In the final stage, capital is no longer simply monitored but actively steered toward its highest-value use.

Chart showing how capital management maturity progresses toward optimizing value.

We have found that an insurer’s capital management expertise depends on three elements: its steering framework, analytical capabilities, and optimization levers.

Steering Framework. Defining the capital steering framework is a board-level responsibility that cuts across finance, risk, actuarial, investments, and the business. It has six key elements. (See Exhibit 2.)

Chart showing the six elements of an effective capital-management framework.
Weekly Insights Subscription
Stay ahead with BCG insights on the insurance industry

At the start of the framework are capital steering KPIs (such as measures for capital generation, cash generation, and solvency) chosen based on the company’s purpose, strategy, and financial objectives. This is why leading exhange-listed insurers and mutual insurers typically steer by different metrics, with the former leaning toward shareholder value measures and the latter toward policyholder value, resilience, and long-term surplus.

Crucially, management connects KPIs—to one another and to the group’s other performance measures—so that it’s clear to stakeholders how operating decisions influence group capital. Management then cascades the decisioning logic consistently from the group level down to business units and legal entities. The most sophisticated carry this logic through to the individual business lines.

Leading insurers deeply embed this steering framework in their operating model. They define and align on tradeoffs (such as how growth is weighed against capital return and how cash is weighed against capital generation) to avoid debating these tradeoffs every time a decision must be made. All this helps these companies direct capital toward their highest risk-adjusted use for growth, balance sheet investment, M&A, and, if applicable, shareholder distributions.

Leading insurers then hardwire these choices into planning, budgeting, and incentives, with clear accountability for outcomes. These insurers also regularly challenge whether solvency targets and management buffers remain economically justified. It is this combination—a well-designed framework that is consistently cascaded, embedded, and acted upon—that turns capital management from a reporting exercise into a steering discipline.

Analytical Capabilities. Many insurers don’t know how their business plan will impact capital until after the plan is set in motion. Moreover, they have limited ability to drill down into business lines, risk types, or drivers. This constraint impedes the optimal steering of capital and cash generation, leaving value on the table.

Leading insurers are investing significantly in analytics to improve financial and capital steering. These capabilities include accessing near-real-time information to monitor capital and financial KPIs against the business plan and forecast (at group, local, and portfolio levels); automatically creating a dashboard with AI-supported root-cause analysis that reveals where performance is diverging and how to respond; and rapidly assessing what-if scenarios and generating answers in minutes rather than weeks.

The effect is that capital analysis is no longer a backward-looking report but a forward-looking input for business decisions. AI is the key enabler of this shift, particularly when combined with faster modeling, better data, and greater automation. Together, these capabilities bring the capital, cash, earnings, and solvency implications into the management dialogue earlier, sharpening decisions and compounding into greater value creation over time. (See Exhibit 3.)

Chart showing how AI reshapes capital analysis to provide fast, forward-looking insight.

Optimization Levers. Leading insurers do not just measure and steer capital, they also invest massively in their optimization capabilities. In the past two to three years, leaders have built up even more skills to optimize capital. With these stepped-up capabilities, they are standing up dedicated teams, deepening actuarial and asset-modeling talent, and giving capital optimization focused management attention. As a result, instead of pulling one lever at time, these insurers are applying several at once.

We have identified well over a hundred distinct levers spanning product and business mix, assets and asset-liability management (ALM), reinsurance, models and assumptions, legal-entity capital and fungibility, treasury and capital structure, and portfolio actions. (See Exhibit 4.) Many insurers have already shown that using multiple levers simultaneously creates substantial impact. For example, a global top-ten insurer identified and upstreamed €4 billion of capital from business units, while a medium-sized European monoliner increased bottom-line capital generation by €300 million per year.

Chart showing capital-optimization levers that yield significant value.

There are two dimensions to optimization excellence. The first is the depth in each individual lever. A sophisticated strategic asset allocation or a well-structured reinsurance solution creates value and an advantage over peers. The allocation also optimizes risk-adjusted value to improve resiliency across several areas, including solvency, liquidity, and management’s ability to respond under adverse scenarios.

The second dimension is breadth and the ability to expertly combine levers based on how they interact. For example, by using internal reinsurance, an insurer can free up capital at a local business unit for reinvestment into growth or a riskier asset allocation to lift future capital generation. Or, by switching from reserves or models that are overly conservative, a company can raise solvency and reinvest in higher-returning assets. Still further, by allocating a larger market-risk budget, an insurer can lift investment returns while consuming solvency headroom. By quantifying the interaction of the levers across capital, cash, earnings, and risk, leading insurers can choose the combination that best serves their objectives. To demonstrate, consider two of these levers: strategic asset allocation and internal and external reinsurance.

Chart showing how multidimensional strategic asset allocation enables real-time decision making.

A Strategic Agenda for CFOs

The link between capital management and value is direct. Insurers that can convert capital strength into cash, growth, and distributions—and can show how—will be rewarded, while those that cannot will face pressure on their valuations. That makes building this capability a strategic priority, not a technical one. Here are five questions CFOs should ask:


The progression of capital management from regulatory compliance to optimized value is not about adding more metrics or optimization levers. It is about moving from knowing how much capital the group has to understanding how its capital moves, what returns it earns, and where to deploy it. It is a discipline that insurers need to master as soon as possible, because after it is in place, it still takes time to assess opportunities, prioritize actions, and implement solutions before the benefits of capital management materialize.

Adding to the internal pressures to create value are the external demands of investors and analysts. Insurers need to develop a credible equity story and clearly articulate how their capital-management strategy will translate into sustainable capital generation, cash, and stakeholder value. The insurers that treat capital management as an integrated capability—and build it deliberately—will turn capital strength into lasting value.